Ionis Pharmaceuticals | IONS - Interest Expense On Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Ionis Pharmaceuticals

Ionis Pharmaceuticals reported $1.61M in Interest Expense on Debt for its fiscal quarter ending in March of 2023.


Interest Expense On Debt Change
Alnylam Pharmaceuticals ALNY:US USD 28.96M 958K
BioCryst Pharmaceuticals BCRX:US USD 27.4M 938K
BioMarin Pharmaceutical BMRN:US USD 3.7M 77K
Esperion Therapeutics ESPR:US USD 14.39M 58K
Halozyme Therapeutics HALO:US USD 4.54M 27K
Intercept Pharmaceuticals ICPT:US USD 2.81M 3K
Moderna Inc MRNA:US USD 9M 1000K
Nektar Therapeutics NKTR:US USD 6.4M 796K
Neurocrine Biosciences NBIX:US USD 1.1M 0
Novartis NOVN:VX USD 211M 8M
Pfizer PFE:US USD 318M 5M
PTC Therapeutics PTCT:US USD 27.33M 1.43M
Regeneron Pharmaceuticals REGN:US USD 18M 600K
Roche Holding ROG:VX CHF 348M 92M
Sarepta Therapeutics SRPT:US USD 6.32M 365K
Vertex Pharmaceuticals VRTX:US USD 11.4M 200K